Economics of Treating Hepatic Encephalopathy With Rifaximin-a Economics of Treating Hepatic Encephalopathy With Rifaximin-a
Rifaximin-alpha is effect in treating hepatic encephalopathy, but its cost is high. Might it still be cost-saving due to reduced hospital admissions and shorter stays?Liver International
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news
More News: Economics | Gastroenterology | Hospitals | Liver | Liver Transplant | Transplant Surgery | Transplants | Urology & Nephrology | Xifaxan